Sorted By:


Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans

PhRMA  |  Blog Post

But we need more data to ensure plans are complying with that law, which requires plans to cover treatment for mental illness under the same terms and conditions as medical and surgical disorders.

Part B Generally Covers Injected & Infused Medicines

PhRMA  |  Graphic

Medicare Part B covers physician office visits, outpatient care, ambulance services and medical equipment like a wheelchair or walker.

Robert Zirkelbach Named PhRMA Executive Vice President

PhRMA  |  Press Release

Zirkelbach serves as a lead spokesman for the association and oversees a team that encompasses media relations, digital/social media, advertising, message development, internal communications and executive visibility.

Clinical Trials - So Necessary But More Complex Than Ever

PhRMA  |  Blog Post

Anyway, the more patients, doctors, policymakers and the media know and understand about how medicines are researched and developed, the better, hopefully, they'll appreciate some of the challenges that America's biopharmaceutical research companies confront in trying to solve some of our toughest health care questions.

Read More About Medicines in Development for Neurological Disorders

PhRMA  |  Report

Related Content: 2015 Report: Medicines in Development for Neurological Disorders (PDF) Press Release: PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders

Will Life Sciences Be Gone Tomorrow?

PhRMA  |  Blog Post

It's clear that to maintain our leadership, we need a medical innovation agenda that ensures a policy and regulatory environment that adequately rewards the innovation that is done across the country by biopharmaceutical research companies.

Placing Innovation at the Forefront of the U.S. Trade Agenda

PhRMA  |  Blog Post

At least five Senators and Congressmen, including Senate Finance Committee Chairman Orrin Hatch, commented directly to Ambassador Froman about the need for robust intellectual property protection for biologic medicines in order to continue progress in one of the most promising areas of medical research.

PhRMA Statement on the President’s Fiscal Year 2013 Budget

PhRMA  |  Press Release

Find PhRMA Online: Website – facebook – Blog – Twitter – and YouTube – For information on how innovative medicines save lives, visit: For information on the Partnership for Prescription Assistance, visit: For information on ensuring the flow of medicines during public health emergencies, visit

As Is Common With Commercial Insurance, Medicare Covers Medicines Under Two Benefits

Chartpack  |  From Our Network

Medicare’s retail pharmacy benefit is called Part D, and Medicare’s medical benefit is called Part B.

Nearly 100 New Medicines in Development for Arthritis

PhRMA  |  Press Release

In addition to information on some of the medicines in the pipeline, the new report delves into treatment advances for rheumatoid arthritis, the importance of collaborative partnerships to advance research, and comprehensive facts about arthritis and related musculoskeletal diseases in the United States.

ICYMI: A Broad Coalition of Stakeholders Continue to Raise Concerns about Patent Litigation Reform

PhRMA  |  Blog Post

As we’ve shared here, here and here on the Catalyst, Congress is currently considering new patent litigation reform legislation.

More Than 70 Medicines in Development for Asthma

PhRMA  |  Press Release

Find PhRMA Online: Website – facebook – Blog – Twitter – and YouTube – For information on how innovative medicines save lives, visit: For information on the Partnership for Prescription Assistance, visit: For information on ensuring the flow of medicines during public health emergencies, visit

Personalized Medicine: Transforming Patient Care

PhRMA  |  Fact Sheet

Personalized medicine, sometimes referred to as precision or individualized medicine, is an emerging field of medicine that uses diagnostic tools to identify specific biological markers, often genetic, to help assess which medical treatments and procedures will be best for each patient.

Combined deductible

Access Better Coverage  |  From Our Network

A deductible – total amount a patient must pay out of pocket annually before the health plan begins to pay – that includes both medical care and prescription medicines.

Maintaining Appropriate Incentives for Biopharmaceutical Innovation

PhRMA  |  Blog Post

President Obama’s recent budget request includes a proposal to reduce data protection for innovative biologics from 12 to seven years.

Joaquin Duato

PhRMA  |  Biography

He is a respected industry leader and is the Chairman-Elect of the Pharmaceutical Research and Manufacturers of America (PhRMA).

340B Paradox: As the Uninsured Rate Drops, 340B Program Continues to Grow

PhRMA  |  Blog Post

(Available at: [viii] Ibid.

Nearly 800 New Medicines in Development to Help in the Fight Against Cancer

PhRMA  |  Press Release

  The report highlights how biopharmaceutical research companies are working together and collaborating with academic medical centers, government and non-profit organizations to make progress against cancer a reality.

U.S. is Still Most Attractive Country for Biopharma Investment; BRICs, Canada Lag Behind

PhRMA  |  Press Release

Meir Pugatch, Managing Director at Pugatch Consilium.

Nearly 200 Medicines in Development for Mental Illnesses

PhRMA  |  Press Release

(July 12, 2012) — America’s biopharmaceutical research companies are developing 187 innovative medicines to help the nearly 60 million patients in the United States who are suffering from some form of mental illness.

The Big Picture in Drug Development

PhRMA  |  Blog Post

We think our animated drug discovery timeline really helps capture the big picture.

PhRMA to Bestow New Research and Hope Award

PhRMA  |  Press Release

The new Award was conceived to recognize the diverse and deserving participants in the larger scientific and patient care ecosystem for their role in helping further medical innovation in the U.S. and providing strong support systems for patients and family members most in need.

Empowering Patients to Be Active Participants in Clinical Trials

PhRMA  |  Blog Post

As I saw at every conference I attended, social media is a huge venue for conversation about clinical trials--and the online patient communities that have developed are inspiring, well-versed in their disease, and looking for answers.

New report: Decade of breakthroughs in cancer

PhRMA  |  Blog Post

Before 2011, the median survival for metastatic melanoma patients was less than a year – recently released data show that in one clinical trial, 40 percent of metastatic melanoma patients have survived three years after initiating immunotherapy.

Rx Response Director Erin Mullen Receives Outstanding Achievement Award

PhRMA  |  Press Release

Widespread media coverage of the PSRT following Sandy quadrupled traffic to the online tool.

You have reviewed the first 400 results out of 1047. Each page contains 25 results. You're on page 16.

prev 13 14 15 16 17 18 next